270 related articles for article (PubMed ID: 35927746)
1. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and relapse risks factors of IgG4 related disease: a single-center retrospective study.
Zhang X; Zeng Z; Tian H; Wang N; Wang Y; Tong J; Chang B; Jin X; Huang D; Wang Y; Cui H; Guan L; Li Y
Clin Exp Med; 2023 Nov; 23(7):3527-3538. PubMed ID: 37392248
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study.
Zongfei J; Lingying M; Lijuan Z; Ying S; Rongyi C; Dongmei L; Xiufang K; Xiaomin D; Lili M; Huiyong C; Lindi J
Clin Rheumatol; 2021 Jun; 40(6):2293-2300. PubMed ID: 33151477
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial.
Peng L; Nie Y; Zhou J; Wu L; Chen X; Wang F; Li J; Peng Y; Lu H; Zhao L; Li M; Zhao Y; Zeng X; Fei Y; Zhang W
Ann Rheum Dis; 2024 Apr; 83(5):651-660. PubMed ID: 38216319
[TBL] [Abstract][Full Text] [Related]
5. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Wang L; Zhang P; Wang M; Feng R; Lai Y; Peng L; Fei Y; Zhang X; Zhao Y; Zeng X; Zhang F; Zhang W
Arthritis Res Ther; 2018 Apr; 20(1):65. PubMed ID: 29636109
[TBL] [Abstract][Full Text] [Related]
6. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
[TBL] [Abstract][Full Text] [Related]
7. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.
Lanzillotta M; Campochiaro C; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L; Della-Torre E
Rheumatology (Oxford); 2020 Sep; 59(9):2435-2442. PubMed ID: 32591828
[TBL] [Abstract][Full Text] [Related]
8. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease.
Martín-Nares E; Saavedra-González V; Fagundo-Sierra R; Santinelli-Núñez BE; Romero-Maceda T; Calderón-Vasquez K; Hernandez-Molina G
Sci Rep; 2021 Jan; 11(1):1832. PubMed ID: 33469111
[TBL] [Abstract][Full Text] [Related]
9. [The clinical characteristics of 346 patients with IgG
Zhang PP; Zhao JZ; Wang M; Feng RE; Liu XW; Lai XM; Li XJ; Zeng JG; Shi HJ; Zhu HD; Xue W; Zhang H; Chen YY; Fei LY; Peng XF; Zeng FC; Zhang YM; Zhang W
Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):644-649. PubMed ID: 28870031
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Liu Y; Zhang Y; Bian W; Fu J; Sun X; Chen D; Chen J; Zhao X; Li Y; Zhang W; Li Z
Clin Rheumatol; 2020 Feb; 39(2):491-497. PubMed ID: 31848912
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
[TBL] [Abstract][Full Text] [Related]
12. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
Liu Y; Zeng Q; Zhu L; Gao J; Wang Z; Wang Z; Yang F; Wang K; Chen D; Xia C; Zhang S; Wang Y; Shen D; Yu G; Li ZG
Rheumatology (Oxford); 2020 Aug; 59(8):2115-2123. PubMed ID: 32097488
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study.
Peng Y; Li JQ; Zhang PP; Zhang X; Peng LY; Chen H; Zhou JX; Zhang SZ; Yang HX; Liu JJ; Guo HF; Li J; Zhang X; Zhao Y; Zeng XF; Zhang FC; Fei YY; Zhang W
J Intern Med; 2019 Nov; 286(5):542-552. PubMed ID: 31121062
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.
Campochiaro C; Ramirez GA; Bozzolo EP; Lanzillotta M; Berti A; Baldissera E; Dagna L; Praderio L; Scotti R; Tresoldi M; Roveri L; Mariani A; Balzano G; Castoldi R; Doglioni C; Sabbadini MG; Della-Torre E
Scand J Rheumatol; 2016; 45(2):135-45. PubMed ID: 26398142
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
[TBL] [Abstract][Full Text] [Related]
16. IgG4-Related Disease: A Retrospective Chinese Study of Features and Treatment Response of 98 Patients Including 4 Rare Cases.
Pan YY; Zhou SC; Wang YJ; Zhu TT; Peng D; Guan HX
Curr Med Sci; 2021 Apr; 41(2):390-397. PubMed ID: 33877558
[TBL] [Abstract][Full Text] [Related]
17. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients.
Wang L; Zhang P; Zhang X; Lin W; Tang H; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Zhang L; Lai Y; Zeng X; Li X; Xue H; Zhao Y; Zhang F; Zhang W
Rheumatology (Oxford); 2019 May; 58(5):820-830. PubMed ID: 30561747
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China.
Zhao Z; Mou D; Wang Z; Zeng Q; Wang Z; Xue J; Ren L; Liu Y; Su Y
Arthritis Res Ther; 2021 Mar; 23(1):98. PubMed ID: 33789746
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients.
Lin W; Lu S; Chen H; Wu Q; Fei Y; Li M; Zhang X; Tian X; Zheng W; Leng X; Xu D; Wang Q; Shen M; Wang L; Li J; Wu D; Zhao L; Wu C; Yang Y; Peng L; Zhou J; Wang Y; Sha Y; Huang X; Jiao Y; Zeng X; Shi Q; Li P; Zhang S; Hu C; Deng C; Li Y; Zhang S; Liu J; Su J; Hou Y; Jiang Y; You X; Zhang H; Yan L; Zhang W; Zhao Y; Zeng X; Zhang F; Lipsky PE
Rheumatology (Oxford); 2015 Nov; 54(11):1982-90. PubMed ID: 26106212
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]